107 related articles for article (PubMed ID: 17132826)
1. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.
Sun HD; Malabunga M; Tonra JR; DiRenzo R; Carrick FE; Zheng H; Berthoud HR; McGuinness OP; Shen J; Bohlen P; Leibel RL; Kussie P
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E964-76. PubMed ID: 17132826
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters.
Samms RJ; Lewis JE; Lory A; Fowler MJ; Cooper S; Warner A; Emmerson P; Adams AC; Luckett JC; Perkins AC; Wilson D; Barrett P; Tsintzas K; Ebling FJ
Curr Biol; 2015 Nov; 25(22):2997-3003. PubMed ID: 26549257
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.
Lelliott CJ; Ahnmark A; Admyre T; Ahlstedt I; Irving L; Keyes F; Patterson L; Mumphrey MB; Bjursell M; Gorman T; Bohlooly-Y M; Buchanan A; Harrison P; Vaughan T; Berthoud HR; Lindén D
PLoS One; 2014; 9(11):e112109. PubMed ID: 25427253
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in rats.
Buss N; Lapointe JM; de Haan L; Price S; Ahnmark A; Irving L; Buchanan A; Keyes F; Davidsson P; Dixit R; Lindén D
Toxicol Appl Pharmacol; 2018 Sep; 355():147-155. PubMed ID: 30008375
[TBL] [Abstract][Full Text] [Related]
5. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
6. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
[TBL] [Abstract][Full Text] [Related]
7. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
8. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
9. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
Larsen PJ; Vrang N; Petersen PC; Kristensen P
Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
[TBL] [Abstract][Full Text] [Related]
10. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
[TBL] [Abstract][Full Text] [Related]
11. Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex.
Foltz IN; Hu S; King C; Wu X; Yang C; Wang W; Weiszmann J; Stevens J; Chen JS; Nuanmanee N; Gupte J; Komorowski R; Sekirov L; Hager T; Arora T; Ge H; Baribault H; Wang F; Sheng J; Karow M; Wang M; Luo Y; McKeehan W; Wang Z; Véniant MM; Li Y
Sci Transl Med; 2012 Nov; 4(162):162ra153. PubMed ID: 23197570
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans.
Baruch A; Wong C; Chinn LW; Vaze A; Sonoda J; Gelzleichter T; Chen S; Lewin-Koh N; Morrow L; Dheerendra S; Boismenu R; Gutierrez J; Wakshull E; Wilson ME; Arora PS
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28992-29000. PubMed ID: 33139537
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.
Aja S; Landree LE; Kleman AM; Medghalchi SM; Vadlamudi A; McFadden JM; Aplasca A; Hyun J; Plummer E; Daniels K; Kemm M; Townsend CA; Thupari JN; Kuhajda FP; Moran TH; Ronnett GV
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R352-61. PubMed ID: 18056987
[TBL] [Abstract][Full Text] [Related]
14. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
[TBL] [Abstract][Full Text] [Related]
15. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.
Egecioglu E; Ploj K; Xu X; Bjursell M; Salomé N; Andersson N; Ohlsson C; Taube M; Hansson C; Bohlooly-Y M; Morgan DG; Dickson SL
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E708-16. PubMed ID: 19584200
[TBL] [Abstract][Full Text] [Related]
16. A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administration.
Peter JC; Lecourt AC; Weckering M; Zipfel G; Niehoff ML; Banks WA; Hofbauer KG
J Pharmacol Exp Ther; 2010 May; 333(2):478-90. PubMed ID: 20118207
[TBL] [Abstract][Full Text] [Related]
17. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.
Salomé N; Hansson C; Taube M; Gustafsson-Ericson L; Egecioglu E; Karlsson-Lindahl L; Fehrentz JA; Martinez J; Perrissoud D; Dickson SL
J Neuroendocrinol; 2009 Sep; 21(9):777-85. PubMed ID: 19703102
[TBL] [Abstract][Full Text] [Related]
18. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
[TBL] [Abstract][Full Text] [Related]
19. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
[TBL] [Abstract][Full Text] [Related]
20. Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates.
Perreault M; Feng G; Will S; Gareski T; Kubasiak D; Marquette K; Vugmeyster Y; Unger TJ; Jones J; Qadri A; Hahm S; Sun Y; Rohde CM; Zwijnenberg R; Paulsen J; Gimeno RE
PLoS One; 2013; 8(5):e62616. PubMed ID: 23700410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
